Literature DB >> 17721105

Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough.

Kimberly Page-Shafer, Judith A Hahn, Paula J Lum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17721105     DOI： 10.1097/QAD.0b013e3282ef7701

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  13 in total

Review 1.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

Review 2.  Evolving epidemiology of hepatitis C virus in the United States.

Authors:  R Monina Klevens; Dale J Hu; Ruth Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

3.  Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

Authors:  April M Young; Dustin B Stephens; Hanan A Khaleel; Jennifer R Havens
Journal:  Contemp Clin Trials       Date:  2014-12-30       Impact factor: 2.226

4.  Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens.

Authors:  E Kainne Dokubo; Jennifer Evans; Valerie Winkelman; Sherri Cyrus; Leslie H Tobler; Alice Asher; Alya Briceno; Kimberly Page
Journal:  J Clin Virol       Date:  2014-01-27       Impact factor: 3.168

5.  Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.

Authors:  William A Zule; Elizabeth C Costenbader; Curtis M Coomes; Wendee M Wechsberg
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

6.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

7.  Strategies to avoid opiate withdrawal: implications for HCV and HIV risks.

Authors:  Pedro Mateu-Gelabert; Milagros Sandoval; Peter Meylakhs; Travis Wendel; Samuel R Friedman
Journal:  Int J Drug Policy       Date:  2009-09-27

8.  Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

Authors:  Jason Grebely; Meghan D Morris; Thomas M Rice; Julie Bruneau; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Naglaa H Shoukry; Georg Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Maria Prins; Gregory J Dore; Kimberly Page
Journal:  Int J Epidemiol       Date:  2012-11-30       Impact factor: 7.196

Review 9.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.